Literature DB >> 8739887

Acute intracerebroventricular administration of neuropeptide Y stimulates corticosterone output and feeding but not insulin output in normal rats.

A Sainsbury1, F Rohner-Jeanrenaud, E Grouzmann, B Jeanrenaud.   

Abstract

The effect of acute intracerebroventricular (i.c.v.) injection of neuropeptide Y (NPY) on basal and glucose- or arginine-stimulated insulinemia was studied in anesthetized and conscious rats. Basal insulinemia was not significantly increased relative to control values after NPY injection. The insulinemic response to an intravenous bolus of glucose or arginine was unaffected by prior NPY injection, glycemic profiles being identical in control and NPY-injected rats. Plasma NPY concentrations were double the corresponding control values at 20 min after i.c.v. NPY injection, but this difference was not statistically significant. Although peripheral NPY inhibits insulin secretion, these elevated plasma NPY concentrations occurred too late to explain the lack of effect of i.c.v. NPY on substrate-induced insulin secretion. Compared to control rats, marked increases in corticosteronemia were observed after i.c.v. NPY injection in conscious animals. When allowed to eat ad libitum at the end of each experiment, NPY-injected rats consumed significantly more chow in 20 min than controls. We conclude that although acute i.c.v. injection of a maximum dose of NPY had definite effects on plasma corticosterone concentrations and feeding, it favored neither the basal nor the substrate-induced insulin output.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8739887     DOI: 10.1159/000126972

Source DB:  PubMed          Journal:  Neuroendocrinology        ISSN: 0028-3835            Impact factor:   4.914


  6 in total

Review 1.  NPY and stress 30 years later: the peripheral view.

Authors:  Dalay Hirsch; Zofia Zukowska
Journal:  Cell Mol Neurobiol       Date:  2012-01-24       Impact factor: 5.046

2.  Chronic central neuropeptide Y infusion in normal rats: status of the hypothalamo-pituitary-adrenal axis, and vagal mediation of hyperinsulinaemia.

Authors:  A Sainsbury; F Rohner-Jeanrenaud; I Cusin; K E Zakrzewska; P A Halban; R C Gaillard; B Jeanrenaud
Journal:  Diabetologia       Date:  1997-11       Impact factor: 10.122

3.  Xiaoyaosan decoction regulates changes in neuropeptide y and leptin receptor in the rat arcuate nucleus after chronic immobilization stress.

Authors:  Shao-Xian Wang; Jia-Xu Chen; Guang-Xin Yue; Ming-Hua Bai; Mei-Jing Kou; Zhong-Ye Jin
Journal:  Evid Based Complement Alternat Med       Date:  2012-11-13       Impact factor: 2.629

4.  Neuropeptide Y reduces expression of social fear via simultaneous activation of Y1 and Y2 receptors.

Authors:  Johannes Kornhuber; Iulia Zoicas
Journal:  J Psychopharmacol       Date:  2019-07-22       Impact factor: 4.153

5.  TCM Formula Xiaoyaosan Decoction Improves Depressive-Like Behaviors in Rats with Type 2 Diabetes.

Authors:  Na Li; Qun Liu; Xiao-Juan Li; Xiao-Hui Bai; Yue-Yun Liu; Hong-Bo Zhao; Zhong-Ye Jin; Yu-Xia Jing; Zhi-Yi Yan; Jia-Xu Chen
Journal:  Evid Based Complement Alternat Med       Date:  2015-10-05       Impact factor: 2.629

6.  Neuropeptide Y as Alternative Pharmacotherapy for Antidepressant-Resistant Social Fear.

Authors:  Johannes Kornhuber; Iulia Zoicas
Journal:  Int J Mol Sci       Date:  2020-11-03       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.